Goldman, Credit Suisse Raided in Seoul in Samsung BioLogics Probe

Prosecutors are reportedly looking for information about a scrapped Nasdaq listing of a Samsung BioLogics subsidiary, to shed light on possible accounting irregularities.

To continue reading...


Get access to Regulation Asia

Regulation Asia delivers the latest news, research and analysis on regulation across banking and capital markets.

Sign up for a free trial or subscribe now. Please click on one of the buttons below.

Free Trial Subscribe

To discuss our subscription options
please email subscriptions@regulationasia.com

To Top